Conference Coverage

VIDEO: Device detects more atrial fibrillation, but when is intervention necessary?


 

AT THE INTERNATIONAL STROKE CONFERENCE

SAN DIEGO – After 6 months, Medtronic’s Reveal XT implant picked up atrial fibrillation in 8.6% of cryptogenic stroke patients. Standard monitoring found it in 1.4%, according to company data presented at the International Stroke Conference. Devices from Medtronic and other companies are going to make detection of asymptomatic atrial fibrillation more common, raising questions about when to intervene. Cardiologist Rod Passman, an investigator for the company, and neurologist Steven Greenberg shared their thoughts on the issue.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

CRT shown highly cost effective in mild heart failure
MDedge Internal Medicine
FDA panel rejects rivaroxaban again for acute coronary syndrome
MDedge Internal Medicine
Personalization keys vision of improved atrial fib care
MDedge Internal Medicine
Cooling the resuscitated sudden dead
MDedge Internal Medicine
CoreValve holds size advantage for U.S. TAVR
MDedge Internal Medicine
DECAAF published: Assess extent of fibrosis before AF ablation
MDedge Internal Medicine
New tools for stroke prediction in atrial fibrillation
MDedge Internal Medicine
Myocardial fibrosis assessment fine-tunes ICD selection
MDedge Internal Medicine
Ablation edges out drugs for treatment-naive paroxysmal atrial fibrillation
MDedge Internal Medicine
Continuous AF monitors raise questions about when to intervene
MDedge Internal Medicine

Related Articles